Company
Headquarters: Istanbul, Türkiye
Employees: 6,574
₺55.77 Billion
TRY as of July 1, 2025
US$1.40 Billion
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Novo Nordisk | $309.91 B |
| UnitedHealth Group | $279.90 B |
Selçuk Ecza Deposu Ticaret ve Sanayi A.S. operates as a distribution channel between pharmaceutical manufacturers, hospitals, and pharmacies. It also operates a pharmaceutical warehouse. The company was founded in 1958 and is headquartered in Istanbul, Turkey. Selçuk Ecza Deposu Ticaret ve Sanayi A.S. is a subsidiary of Selçuk Ecza Holding A.S.
| Last Financial Reports Date | March 31, 2025 |
| Revenue TTM | ₺127.65 B |
| EBITDA | ₺5.09 B |
| Gross Profit TTM | ₺11.49 B |
| Profit Margin | 1.35% |
| Operating Margin | 1.11% |
| Quarterly Revenue Growth | -2.50% |
Selçuk Ecza Deposu Ticaret ve Sanayi A.S. has the following listings and related stock indices.
Stock: BIST: SELEC wb_incandescent